The LDN 2017 Conference
We would like to thank all the speakers for taking part in the conference, and for their amazing presentations.
We would like to thank all the speakers for taking part in the conference, and for their amazing presentations.
Presentations on LDN pharmacology; the opioid system; and LDN’s role in treating autoimmune disorders eg Ehlers-Danlos Syndrome (EDS), eosinophilic esophagitis, myasthenia gravis, glycogen storage disorder (GSD VII), pemphigus vulgaris, Crackly Brain or Middle Ear Myoclonus (MEM), multiple sclerosis (MS), Parkinson’s, Lyme disease, Type 1 diabetes (T1DM), psoriasis and psoriatic arthritis, Crohn’s, vitiligo, cancer and cancer therapy, pain, CFS/ME, fibromyalgia, lupus, irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO); gut dysbiosis, nutrition, and gut healing; Vitamin D3, thyroid disorders, Hashimoto’s HIV/AIDS, hormone balance, autism, traumatic brain injury (TBI), post-traumatic stress disorders, pets, gastroparesis, rheumatoid arthritis, alcohol use disorder, phobias, children, complex regional pain syndrome (CPRS), celiac disease, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), ulcerative colitis, lichen, mental health and substance abuse disorders.